XML 39 R24.htm IDEA: XBRL DOCUMENT
v3.25.2

SEGMENT AND RELATED INFORMATION | 12 Months Ended
--- | ---
Jun. 30, 2025
Segment Reporting [Abstract] |
SEGMENT AND RELATED INFORMATION | NOTE 15 - SEGMENT AND RELATED INFORMATION The Company provides segment data in accordance with the provisions of ASC 280, “Disclosures about Segments of an Enterprise and Related Information” which was adopted during our fiscal ending June 30, 2025. Our chief operating decision maker (“CODM”), who is also our CEO, evaluates the financial performance of our segments based upon their respective revenue and segmented internal profit and loss statements prepared on a basis not consistent with GAAP. The CODM considers actual to budget and current year actual to prior year actual for revenue and other profit and loss measures on a monthly basis for evaluating performance of each segment and making decisions about allocating capital and other resources to each segment. The Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging centers. The accounting policies of the segments are the same as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company evaluates performance based on income or loss from operations. Summarized financial information concerning the Company’s reportable segments is shown in the following table: Summarized Segment Financial Information
Schedule of Segment Financial Information |  |  |  |  |  |  |  |  |  |  |  |
|  | Manufacturing and Servicing of Medical |  | Management of Diagnostic Imaging |  |
Fiscal 2025: |  | Equipment |  | Centers |  | Totals
Net revenues from external customers |  | $ | 8,977,349 |  |  | $ | 95,373,969 |  |  | $ | 104,351,318 |
Cost of Sales |  |  |  |  |  |  |  |  |  |  |  |
Salaries and wages |  |  | 2,905,311 |  |  |  | 19,384,410 |  |  |  | 22,289,721 |
Rent expense |  |  | — |  |  |  | 4,822,044 |  |  |  | 4,822,044 |
Other Cost of sales expenses** |  |  | 2,944,740 |  |  |  | 31,385,807 |  |  |  | 34,330,547 |
Total Cost of sales |  | $ | 5,850,051 |  |  | $ | 55,592,261 |  |  | $ | 61,442,312 |
Research and development |  |  |  |  |  |  |  |  |  |  |  |
Salaries and wages |  |  | 766,963 |  |  |  | — |  |  |  | 766,963 |
Other research and development costs** |  |  | 809,123 |  |  |  | — |  |  |  | 809,123 |
Total Research and development costs |  | $ | 1,576,086 |  |  | $ | — |  |  |  | 1,576,086 |
Selling, general and administrative expenses |  |  |  |  |  |  |  |  |  |  |  |
Salaries and wages |  |  | 4,934,716 |  |  |  | 10,983,643 |  |  |  | 15,918,359 |
Rent expense |  |  | 1,251,924 |  |  |  | 36,528 |  |  |  | 1,288,452 |
Other selling, general and administrative expenses** |  |  | 2,970,693 |  |  |  | 9,556,659 |  |  |  | 12,527,352 |
Total Selling, general and administrative expenses |  | $ | 9,157,333 |  |  | $ | 20,576,830 |  |  | $ | 29,734,163 |
Total costs and expenses |  | $ | 16,619,740 |  |  | $ | 76,133,091 |  |  | $ | 92,752,561 |
(Loss) Income from operations |  | $ | (7,606,121 | ) |  | $ | 19,204,878 |  |  | $ | 11,598,757 |
Investment income |  |  | 107,777 |  |  |  | 2,011,203 |  |  |  | 2,118,980 |
Other income |  |  | 52,508 |  |  |  | 9,993 |  |  |  | 62,501 |
(Loss) Income before provision for income taxes |  | $ | (7,445,836 | ) |  | $ | 21,226,074 |  |  | $ | 13,780,238 |
Provision for income taxes |  |  | (2,885,852 | ) |  |  | (220,953 | ) |  |  | (3,106,805 | )
Net (Loss) income |  | $ | (10,331,688 | ) |  | $ | 21,005,121 |  |  | $ | 10,673,433 |
Intersegment net revenues * |  |  | 1,189,130 |  |  |  | — |  |  |  | 1,189,130 |
Depreciation and amortization |  |  | 209,325 |  |  |  | 4,488,996 |  |  |  | 4,698,321 |
Total identifiable assets |  | $ | 34,401,915 |  |  | $ | 182,646,336 |  |  | $ | 217,048,251 |
Capital expenditures |  |  | 375,599 |  |  |  | 3,441,307 |  |  |  | 3,816,906 |
Fiscal 2024: |  |  |  |  |  |  |  |  |  |  |  |
Net revenues from external customers |  | $ | 8,329,106 |  |  | $ | 94,554,983 |  |  | $ | 102,884,089 |
Cost of Sales |  |  |  |  |  |  |  |  |  |  |  |
Salaries and wages |  |  | 2,684,218 |  |  |  | 18,913,412 |  |  |  | 21,597,630 |
Rent expense |  |  | — |  |  |  | 4,532,535 |  |  |  | 4,532,535 |
Other Cost of sales expenses** |  |  | 2,089,924 |  |  |  | 29,523,955 |  |  |  | 31,613,879 |
Total Cost of sales |  | $ | 4,774,142 |  |  | $ | 52,969,902 |  |  | $ | 57,744,044 |
Research and development |  |  |  |  |  |  |  |  |  |  |  |
Salaries and wages |  |  | 781,012 |  |  |  | — |  |  |  | 781,012 |
Other research and development costs** |  |  | 954,937 |  |  |  | — |  |  |  | 954,937 |
Total Research and development costs |  | $ | 1,735,949 |  |  | $ | — |  |  | $ | 1,735,949 |
Selling, general and administrative expenses |  |  |  |  |  |  |  |  |  |  |  |
Salaries and wages |  |  | 4,794,512 |  |  |  | 10,156,520 |  |  |  | 14,951,032 |
Rent expense |  |  | 1,076,069 |  |  |  | 73,676 |  |  |  | 1,149,745 |
Other selling, general and administrative expenses** |  |  | 2,906,446 |  |  |  | 7,861,509 |  |  |  | 10,767,955 |
Selling, general and administrative expenses |  | $ | 8,777,027 |  |  | $ | 18,091,705 |  |  | $ | 26,868,732 |
Total costs and expenses |  | $ | 15,287,118 |  |  | $ | 71,061,607 |  |  | $ | 86,348,725 |
(Loss) Income from operations |  | $ | (6,958,012 | ) |  | $ | 23,493,376 |  |  | $ | 16,535,364 |
Investment income |  |  | 120,387 |  |  |  | 2,006,052 |  |  |  | 2,126,439 |
Other income (expenses) |  |  | 640,952 |  |  |  | (36,370 | ) |  |  | 604,582 |
(Loss) Income before provision for income taxes |  | $ | (6,196,673 | ) |  | $ | 25,463,058 |  |  | $ | 19,266,385 |
Provision for income taxes |  |  | (4,788,028 | ) |  |  | (380,940 | ) |  |  | (5,168,968 | )
Net (Loss) income |  | $ | (10,984,701 | ) |  | $ | 25,082,118 |  |  | $ | 14,097,417 |
Intersegment net revenues * |  |  | 1,073,333 |  |  |  | — |  |  |  | 1,073,333 |
Depreciation and amortization |  |  | 238,802 |  |  |  | 4,357,619 |  |  |  | 4,596,421 |
Total identifiable assets |  | $ | 30,360,188 |  |  | $ | 183,885,781 |  |  | $ | 214,245,969 |
Capital expenditures |  |  | 32,885 |  |  |  | 789,961 |  |  |  | 822,846 |
* | Amounts eliminated in consolidation
** | Other segment costs include supplies, professional fees, marketing expenses, repairs and maintenance and other operational costs.
Export Product Sales The Company’s areas of operations are principally in the United States. The Company had export sales of medical equipment amounting to 1.4% and 0.2% of product sales revenues to third parties for the years ended June 30, 2025 and 2024, respectively. The foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:
Schedule of export product sales |  |  |  |  |  |  |  |
|  | For the Years Ended June 30
|  | 2025 |  | 2024
Canada |  |  | — |  |  |  | 0.2 | %
Puerto Rico |  |  | 1.4 | % |  |  | — |
|  |  | 1.4 | % |  |  | 0.2 | %
Foreign Service and Repair Fees The Company’s areas of service and repair are principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to 7.7% and 7.4% of consolidated net service and repair fees for the years ended June 30, 2025 and 2024, respectively. Foreign service and repair fees, as a percentage of total service and repair fees, were provided principally to the following countries: Foreign Service and Repair Fees
Schedule of Foreign Service and Repair Fees |  |  |  |  |  |  |  |
|  | For the Years Ended June 30,
|  | 2025 |  | 2024
Puerto Rico |  |  | 1.3 | % |  |  | 1.9 | %
Switzerland |  |  | 0.3 |  |  |  | 0.3 |
Germany |  |  | 3.0 |  |  |  | 2.0 |
England |  |  | 1.3 |  |  |  | 0.7 |
United Arab Emirates |  |  | 0.1 |  |  |  | 0.3 |
Dominican Republic |  |  | 1.2 |  |  |  | 1.2 |
Canada |  |  | 0.1 |  |  |  | — |
Greece |  |  | 0.4 |  |  |  | 0.3 |
Australia |  |  | — |  |  |  | 0.7 |
|  |  | 7.7 | % |  |  | 7.4.4 | %
The Company does not have any material assets outside of the United States.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 12: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 14: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 15: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 16: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration